E
Keros Therapeutics, Inc. KROS
$11.58 $0.110.96%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 3.04M 388.00K 37.00K 83.00K 143.00K
Total Other Revenue -- -- -- -- --
Total Revenue 3.04M 388.00K 37.00K 83.00K 143.00K
Cost of Revenue -109.70M 49.23M 40.52M 38.26M -83.68M
Gross Profit 112.75M -48.84M -40.48M -38.18M 83.83M
SG&A Expenses 10.67M 9.82M 9.96M 10.31M 9.11M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 56.30M 59.05M 50.48M 48.57M 46.60M
Operating Income -53.25M -58.66M -50.44M -48.48M -46.46M
Income Before Tax -45.73M -52.96M -45.26M -43.11M -40.24M
Income Tax Expenses 300.00K -- -- -- --
Earnings from Continuing Operations -46.03M -52.96M -45.26M -43.11M -40.24M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -46.03M -52.96M -45.26M -43.11M -40.24M
EBIT -53.25M -58.66M -50.44M -48.48M -46.46M
EBITDA -52.92M -58.34M -50.13M -48.21M -46.21M
EPS Basic -1.14 -1.41 -1.25 -1.21 -1.34
Normalized Basic EPS -0.71 -0.88 -0.78 -0.76 -0.83
EPS Diluted -1.14 -2.82 -1.25 -1.21 -1.34
Normalized Diluted EPS -0.71 -0.88 -0.78 -0.76 -0.83
Average Basic Shares Outstanding 40.34M 37.59M 36.10M 35.69M 30.13M
Average Diluted Shares Outstanding 40.34M 37.59M 36.10M 35.69M 30.13M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings